Fennec Pharmaceuticals (FENC) Net Margin (2020 - 2025)
Fennec Pharmaceuticals posted quarterly Net Margin of 15.48% for Q4 2025, up 3442.0% year-on-year from 0.44% in Q4 2024, and up 409.7% on a QoQ basis from 5.0% in Q3 2025.
Fennec Pharmaceuticals (FENC) has 4 years of Net Margin data on file, last reported at 15.48% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 3442.0% year-over-year to 15.48%; the trailing twelve-month figure through Dec 2025 stood at 6.29% (down 667.0% YoY), and the FY2025 full-year result was 21.82%, down 4718.0% from the prior year.
- Net Margin for Q4 2025 stood at 15.48%, up from 5.0% in the prior quarter.
- Across five years, Net Margin topped out at 50.86% in Q1 2024 and bottomed at 355.34% in Q1 2023.
- The 3-year median for Net Margin is 27.04% (2023), against an average of 61.04%.
- The widest annual swing landed in 2024, when Net Margin surged 40619 bps; it then sank 6416 bps in 2025.
- A 3-year view of Net Margin shows it stood at 26.89% in 2023, then climbed by 30 bps to 18.94% in 2024, then jumped by 182 bps to 15.48% in 2025.
- The last three Net Margin figures came in at 15.48% (Q4 2025), 5.0% (Q3 2025), and 32.69% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 15.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.48% |
| Sep 30, 2025 | -5.00% |
| Jun 30, 2025 | -32.69% |
| Mar 31, 2025 | -13.30% |
| Dec 31, 2024 | -18.94% |
| Sep 30, 2024 | -81.89% |
| Jun 30, 2024 | -75.92% |
| Mar 31, 2024 | 50.86% |
| Dec 31, 2023 | -26.89% |
| Sep 30, 2023 | -27.18% |
| Jun 30, 2023 | -161.68% |
| Mar 31, 2023 | -355.34% |
| Dec 31, 2020 | -1,666.50% |